Neptune Technologies & Bioressources Inc. is a biotechnology company engaged in the research and development of extraction technologies. The Company�s main focuses is to identify marine biomasses pure from toxins, abundant and underexploited; to research, develop and commercialize technology for the extraction and stabilization of potent marine biological therapeutic agents, and to research and develop the safety and therapeutic efficacy of compounds for prevalent atherosclerotic conditions. It operates in three segments: Neptune, Acasti Pharma Inc. and NeuroBioPharm Inc. Its Neptune segment is engaged in the manufacturing and commercialization of nutraceutical products. Its Acasti Pharma segment is involved in the development and commercialization of pharmaceutical applications for cardiovascular diseases. Its NeuroBioPharma segment is involved in the development of commercialization of pharmaceutical products for neurological diseases.